MICRON TECHNOLOGY INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent ($276.0m) $5.1b $14.1b $6.3b $2.7b $5.9b $8.7b ($5.8b) $778.0m $8.5b
Net Income (Loss) Attributable to Noncontrolling Interest $1.0m $1.0m $3.0m $45.0m $23.0m $0 $0
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest ($275.0m) $5.1b $14.1b $6.4b $2.7b $5.9b $8.7b
Amortization of Debt Issuance Costs and Discounts $126.0m $125.0m $101.0m $49.0m $26.0m $30.0m
Amortization of Intangible Assets $117.0m $106.0m $82.0m $85.0m $86.0m $82.0m $71.0m
Depreciation $2.9b $3.8b $4.7b $5.3b $5.6b $6.1b $7.0b $7.7b $7.7b $8.3b
Depreciation expense and amortization of intangible assets $3.0b $3.9b $4.8b $5.4b $5.7b $6.2b $7.1b $7.8b $7.8b $8.4b
Depreciation, Depletion and Amortization $2.9b $3.8b $4.8b $5.4b $5.7b $6.2b $7.1b $7.8b $7.8b $8.4b
Deferred Income Tax Expense (Benefit) ($9.0m) ($259.0m) $336.0m $110.0m ($19.0m) $294.0m ($7.0m) $35.0m $164.0m
Deferred Other Tax Expense (Benefit) ($1.3b)
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount $7.0m $32.0m $10.0m
Gain (Loss) on Sale of Assets and Asset Impairment Charges $128.0m
Goodwill impairment $0 $0 $101.0m $0 $0
Goodwill, Impairment Loss $101.0m $0 $0
Payment, Tax Withholding, Share-based Payment Arrangement $125.0m
Restructuring Costs and Asset Impairment Charges $454.0m $44.0m $11.0m
Share-based Payment Arrangement, Expense $243.0m $328.0m $395.0m $496.0m $557.0m $821.0m $975.0m
Share-based Payment Arrangement, Noncash Expense $191.0m $215.0m $198.0m $243.0m $328.0m $378.0m $514.0m $596.0m $833.0m $972.0m
Equity Method Investment, Realized Gain (Loss) on Disposal $0
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property $4.0m $22.0m $96.0m ($43.0m) $3.0m $24.0m $41.0m $54.0m $59.0m ($15.9b)
Gain (Loss) on Extinguishment of Debt ($4.0m) ($99.0m) ($385.0m) ($396.0m) $40.0m ($1.0m) ($83.0m) $0 ($59.0m)
Income (Loss) from Equity Method Investments $25.0m $8.0m ($1.0m) $3.0m $7.0m $37.0m $4.0m $2.0m ($11.0m) $9.0m
Income Tax Expense (Benefit) $19.0m $114.0m $168.0m $693.0m $280.0m $394.0m $888.0m $177.0m $451.0m $1.1b
Interest Expense Nonoperating $562.0m $477.0m
Other Nonoperating Income (Expense) ($54.0m) ($112.0m) ($465.0m) ($405.0m) $60.0m $81.0m ($38.0m) $7.0m ($31.0m) ($135.0m)
Changes in operating assets and liabilities:
Additional Financial Items
Non-cash transactions:
Accounts payable and accrued expenses $272.0m $564.0m $549.0m ($174.0m) $725.0m $210.0m $744.0m ($2.1b) $1.9b $862.0m
Foreign Currency Transaction Gain (Loss), before Tax ($24.0m) ($74.0m) ($75.0m) ($9.0m) ($8.0m) ($72.0m)
Gain (Loss) Related to Litigation Settlement $0
Gain (Loss) on Investments $82.0m $26.0m ($8.0m)
Goodwill $1.2b $1.2b $1.2b $1.2b $1.2b $1.2b $1.1b $1.1b $1.1b
Increase (Decrease) in Inventories $549.0m ($50.0m) $472.0m $1.5b $489.0m ($866.0m) $2.2b $3.6b $488.0m ($520.0m)
Inventories ($549.0m) $50.0m ($472.0m) ($1.5b) ($489.0m) $866.0m ($2.2b) ($3.6b) ($488.0m) $520.0m
Inventory Write-down $1.8b $0 $0
Litigation Settlement Loss $0 $0
Non-cash equipment acquisitions on contracts payable $993.0m $813.0m $84.0m $119.0m $278.0m $165.0m $118.0m $321.0m
Other ($148.0m) $8.0m ($40.0m) ($23.0m) ($118.0m) $140.0m $211.0m $95.0m $18.0m ($139.0m)
Other current liabilities $400.0m ($817.0m) $989.0m ($272.0m)
Proceeds from Stock Options Exercised $142.0m
Proceeds from government incentives $16.0m $21.0m $355.0m $748.0m $262.0m $495.0m $115.0m $710.0m $315.0m $2.0b
Proceeds from maturities and sales of available-for-sale securities $3.7b $970.0m $1.6b $1.6b $1.8b $1.7b
Provision to write down inventories to net realizable value $0 $0 $1.8b $0 $0
Purchases of available-for-sale securities ($1.0b) ($1.2b) ($760.0m) ($4.2b) ($1.9b) ($3.2b) ($1.8b) ($723.0m) ($2.0b) ($1.9b)
Receivables $465.0m ($1.7b) ($1.7b) $2.4b ($723.0m) ($1.4b) $190.0m $2.8b ($3.6b) ($1.8b)
Stock-based compensation $191.0m $215.0m $198.0m $243.0m $328.0m $378.0m $514.0m $596.0m $833.0m $972.0m
Derivative, Gain (Loss) on Derivative, Net $183.0m
Other Operating Income (Expense), Net $6.0m $17.0m $57.0m ($49.0m) ($68.0m) ($95.0m) $34.0m ($124.0m) $251.0m ($61.0m)
Net Cash Provided by (Used in) Operating Activities $3.2b $8.2b $17.4b $13.2b $8.3b $12.5b $15.2b $1.6b $8.5b $17.5b
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $5.8b $4.7b $8.9b $9.8b $8.2b $10.0b $12.1b $7.7b $8.4b $15.9b
Property, plant and equipment acquisitions funded by liabilities $5.8b $4.7b $8.9b $9.8b $8.2b $10.0b $12.1b $7.7b $8.4b $15.9b
Payments to Acquire Businesses, Net of Cash Acquired $2.6b $0 $0
Payments for (Proceeds from) Other Investing Activities $81.0m ($190.0m) ($166.0m) ($120.0m) $43.0m ($3.0m) $366.0m $93.0m $33.0m $43.0m
Net cash used for investing activities ($3.0b) ($7.5b) ($8.2b) ($10.1b) ($7.6b) ($10.6b) ($11.6b) ($6.2b) ($8.3b) ($14.1b)
Net Cash Provided by (Used in) Investing Activities ($3.0b) ($7.5b) ($8.2b) ($10.1b) ($7.6b) ($10.6b) ($11.6b) ($6.2b) ($8.3b) ($14.1b)
Cash flows from financing activities:
Proceeds from Issuance of Long-term Debt $2.2b $3.3b $1.0b $3.5b $5.0b $1.2b $2.0b $6.7b $999.0m $4.4b
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale $3.7b $970.0m $320.0m $1.5b $814.0m $1.2b $1.3b $1.6b $1.8b $1.7b
Proceeds from issuance of debt $2.2b $3.3b $1.0b $3.5b $5.0b $1.2b $2.0b $6.7b $999.0m $4.4b
Repayments of debt ($870.0m) ($2.6b) ($10.2b) ($3.3b) ($4.4b) ($1.5b) ($2.0b) ($761.0m) ($1.9b) ($4.6b)
Payments for Repurchase of Common Stock $148.0m $35.0m $71.0m $2.7b $251.0m $1.3b $2.4b $425.0m $300.0m $0
Payments of Ordinary Dividends, Common Stock $461.0m $504.0m $513.0m $522.0m
Repurchases of common stock - repurchase program ($148.0m) ($35.0m) ($71.0m) ($2.7b) ($251.0m) ($1.3b) ($2.4b) ($425.0m) ($300.0m) $0
Proceeds from Noncontrolling Interests $37.0m
Payments of dividends to shareholders $0 $0 ($461.0m) ($504.0m) ($513.0m) ($522.0m)
Proceeds from (Payments for) Other Financing Activities ($148.0m) $8.0m ($40.0m) ($23.0m) ($118.0m) $140.0m $211.0m $95.0m $18.0m ($139.0m)
Net cash provided by (used for) financing activities $1.7b $349.0m ($7.8b) ($2.4b) ($317.0m) ($1.8b) ($3.0b) $5.0b ($1.8b) ($850.0m)
Net Cash Provided by (Used in) Financing Activities $1.7b $349.0m ($7.8b) ($2.4b) ($317.0m) ($1.8b) ($3.0b) $5.0b ($1.8b) ($850.0m)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $19.0m ($12.0m) ($37.0m) $26.0m $11.0m $41.0m ($106.0m) ($34.0m) $40.0m $6.0m
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash $19.0m ($12.0m) ($37.0m) $26.0m $11.0m $41.0m ($106.0m) ($34.0m) $40.0m $6.0m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $19.0m $953.0m $1.4b $692.0m $411.0m $139.0m $510.0m $317.0m ($1.6b) $2.6b
Net increase (decrease) in cash, cash equivalents, and restricted cash $1.9b $953.0m $1.4b $692.0m $411.0m $139.0m $510.0m $317.0m ($1.6b) $2.6b
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $19.0m $5.2b $6.6b $7.3b $7.7b $7.8b $8.3b $8.7b $7.1b $9.6b
Cash, cash equivalents, and restricted cash at beginning of period $4.3b $5.2b $6.6b $7.3b $7.7b $7.8b $8.3b $8.7b $7.1b $9.6b
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $267.0m $468.0m $312.0m $53.0m $165.0m $171.0m $154.0m $323.0m $503.0m $418.0m
Income Taxes Paid, Net $90.0m $99.0m $226.0m $524.0m $167.0m $361.0m $493.0m $532.0m $338.0m $583.0m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.